| Trial name or title |
Cyclosporin A (Neoral) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) requiring repetitive administration of high‐dose intravenous immunoglobulin. |
| Methods |
Parallel group, open, randomised. |
| Participants |
"Definite or probable CIDP according to classification criteria of the EFNS/PNS CIDP guideline" |
| Interventions |
"Cyclosporin A is given orally at an initial dose of 3 mg/kg/day. The dosage of cyclosporine A is adjusted to keep a serum trough concentration between 100 and 150 ng/ml. Administration of high‐dose intravenous immunoglobulin (0.4g/kg) is continued same as observation period" |
| Outcomes |
Primary outcomes: neurological symptom; frequency of high‐dose intravenous immunoglobulin; toxicity. |
| Starting date |
1 August 2006 |
| Contact information |
Shu‐ichi Ikeda 0263‐37‐2671; hmorita@hsp.md.shinshu‐u.ac.jp |
| Notes |
ICTRP Search Portal JPRN‐UMIN000000674 |
